Ayaka Koga

Dr. Ayaka Koga

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Wataru AriyoshiWataru Ariyoshi
Wataru Ariyoshi
SHShiika Hara
Shiika Hara
AKAyaka Koga
Ayaka Koga
YNYoshie Nagai-Yoshioka
Yoshie Nagai-Yoshioka
RYRyota Yamasaki
Ryota Yamasaki
Although the anti-tumor and anti-infective properties of β-glucans have been well-discussed, their role in bone metabolism has not been reviewed so far. This review discusses the biological effects of β-glucans on bone metabolisms, especially on bone-resorbing osteoclasts, which are differentiated from hematopoietic precursors. Multiple immunoreceptors that can recognize β-glucans were reported to be expressed in osteoclast precursors. Coordinated co-stimulatory signals mediated by these immunoreceptors are important for the regulation of osteoclastogenesis and bone remodeling. Curdlan from the bacterium Alcaligenes faecalis negatively regulates osteoclast differentiation in vitro by affecting both the osteoclast precursors and osteoclast-supporting cells. We also showed that laminarin, lichenan, and glucan from baker’s yeast, as well as β-1,3-glucan from Euglema gracilisas, inhibit the osteoclast formation in bone marrow cells. Consistent with these findings, systemic and local administration of β-glucan derived from Aureobasidium pullulans and Saccharomyces cerevisiae suppressed bone resorption in vivo. However, zymosan derived from S. cerevisiae stimulated the bone resorption activity and is widely used to induce arthritis in animal models. Additional research concerning the relationship between the molecular structure of β-glucan and its effect on osteoclastic bone resorption will be beneficial for the development of novel treatment strategies for bone-related diseases.

27 April 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
AKAyaka Koga
Ayaka Koga
CTChuencheewit Thongsiri
Chuencheewit Thongsiri
DKDaisuke Kudo
Daisuke Kudo
PDPhuong Nguyen Duy Dao
Phuong Nguyen Duy Dao
YIYoshihito Iwamoto
Yoshihito Iwamoto
Wataru AriyoshiWataru Ariyoshi
Wataru Ariyoshi
In recent years, magnesium hydroxide has been widely studied due to its bioactivity and biocompatibility. The bactericidal effects of magnesium hydroxide nanoparticles on oral bacteria have also been reported. Therefore, in this study, we investigated the biological effects of magnesium hydroxide nanoparticles on inflammatory responses induced by periodontopathic bacteria. Macrophage-like cells, namely J774.1 cells, were treated with LPS derived from Aggregatibacter actinomycetemcomitans and two different sizes of magnesium hydroxide nanoparticles (NM80/NM300) to evaluate their effects on the inflammatory response. Statistical analysis was performed using an unresponsive Student’s t-test or one-way ANOVA followed by Tukey’s post hoc test. NM80 and NM300 inhibited the expression and secretion of IL-1β induced by LPS. Furthermore, IL-1β inhibition by NM80 was dependent on the downregulation of PI3K/Akt-mediated NF-κB activation and the phosphorylation of MAPK molecules such as JNK, ERK1/2, and p38 MAPK. By contrast, only the deactivation of the ERK1/2-mediated signaling cascade is involved in IL-1β suppression by NM300. Although the molecular mechanism involved varied with size, these results suggest that magnesium hydroxide nanoparticles have an anti-inflammatory effect against the etiologic factors of periodontopathic bacteria. These properties of magnesium hydroxide nanoparticles can be applied to dental materials.

AKAyaka Koga
Ayaka Koga
Wataru AriyoshiWataru Ariyoshi
Wataru Ariyoshi
KKKaoru Kobayashi
Kaoru Kobayashi
MIMaya Izumi
Maya Izumi
AIAyaka Isobe
Ayaka Isobe
TNTatsuji Nishihara
Tatsuji Nishihara
Background: Periodontal pathogens are related to the incidence of systemic diseases. This study aimed to examine whether periodontal pathogen burden is associated with the risk of fever onset in older adults. Methods: Older adults in nursing homes, aged ≥65 years, were enrolled. The study was set in Kitakyushu, Japan. The body temperatures of participants were ≥37.2 °C and were recorded for eight months. As periodontal pathogens, Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia were qualified by a real-time polymerase chain reaction at the baseline. For statistical analysis, the number of bacterial counts was logarithmically conversed to 10 as a base. Results: Data from 56 participants with a median age of 88 (62–98) years were available for analysis. The logarithmic-conversed bacterial counts of T. forsythia, but not P. gingivalis or T. denticola, were associated with the onset of fever in older residents. The Kaplan–Meier method revealed that the group with <104 of T. forsythia had significantly less cumulative fever incidence than the group with ≥104 of T. forsythia. The group with ≥104 of T. forsythia was associated with an increased risk of fever onset (hazard ratio, 3.7; 98% confidence interval, 1.3–10.2; p = 0.012), which was adjusted for possible confounders. Conclusions: Bacterial burden of T. forsythia in the oral cavity was associated with the risk of the onset of fever in older nursing homes residents.

28 November 2024 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
AKAyaka Koga
Ayaka Koga
YYYoshie Yoshioka
Yoshie Yoshioka
RYRyota Yamasaki
Ryota Yamasaki
YAYoshiyuki Adachi
Yoshiyuki Adachi
WFWataru Fujii
Wataru Fujii
Wataru AriyoshiWataru Ariyoshi
Wataru Ariyoshi

11 January 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
KMKazuki Maruyama
Kazuki Maruyama
AKAyaka Koga
Ayaka Koga
YKYuki Kodama
Yuki Kodama
RYRyota Yamasaki
Ryota Yamasaki
YYYoshie Yoshioka
Yoshie Yoshioka
Wataru AriyoshiWataru Ariyoshi
Wataru Ariyoshi
Background/Objectives: Surfactin is a biosurfactant with various biological activities, including antibacterial and anti-inflammatory properties; however, its effects on bone metabolism remain poorly understood. This study aimed to investigate the effects of surfactin on osteoclast differentiation and elucidate its underlying molecular mechanisms. Methods: RAW264.7 cells were treated with receptor activator of nuclear factor-kappa B ligand (RANKL) and surfactin, and osteoclast differentiation and maturation were evaluated by tartrate-resistant acid phosphatase and F-actin staining, respectively. Gene expression of differentiation markers was assessed using real-time reverse transcription-quantitative polymerase chain reaction, while the kinetics of intracellular signaling molecules and transcription factors were analyzed using Western blot analysis. Results: Surfactin treatment significantly inhibited osteoclast differentiation and maturation, as well as the mRNA expression of Nfatc1, Acp5, and Cathepsin K. Although surfactin did not markedly affect RANKL-induced activation of the NF-κB or MAPK-mediated signaling, it significantly suppressed the expression of c-Fos at both the mRNA and protein levels. Furthermore, surfactin attenuated the phosphorylation of Elk1, a transcription factor involved in c-Fos induction. Conclusions: Surfactin inhibits RANKL-induced osteoclast differentiation by negatively regulating the Elk1-AP-1-NFATc1 axis. Surfactin may thus be a promising therapeutic candidate for the treatment of metabolic bone disorders and inflammatory bone destruction.

24 January 2025 in Carbohydrate Polymer Technologies and Applications
Verified
Journal Article
Open access
Wataru AriyoshiWataru Ariyoshi
Wataru Ariyoshi
AKAyaka Koga
Ayaka Koga
YKYuki Kodama
Yuki Kodama
RYRyota Yamasaki
Ryota Yamasaki
YYYoshie Yoshioka
Yoshie Yoshioka
YAYoshiyuki Adachi
Yoshiyuki Adachi